Merit Medical Systems Stock
Merit Medical Systems Stock
The stock is an absolute favorite of our community with 27 Buy predictions and no Sell predictions.
With a target price of 91 € there is a hugely positive potential of 55.56% for Merit Medical Systems compared to the current price of 58.5 €.
Pros and Cons of Merit Medical Systems in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Merit Medical Systems vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Merit Medical Systems | - | -2.521% | -10.769% | -40.513% | -21.622% | -14.074% | 13.725% |
| Bio-Rad Labs Inc. A | -0.660% | 2.341% | 5.300% | 8.094% | -6.786% | -44.455% | -50.535% |
| Haemonetics Corp. | 0.820% | -5.000% | -10.182% | - | -27.883% | - | - |
| Neogen Corp. | 1.920% | 1.258% | -16.146% | 3.205% | 30.894% | - | - |
Comments
Merit Medical Systems (MMSI) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $101.00 price target on the stock.
Show more
Ratings data for MMSI provided by MarketBeat
Merit Medical Systems (MMSI) had its price target raised by Barrington Research from $106.00 to $109.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MMSI provided by MarketBeat
Merit Medical Systems (MMSI) had its price target lowered by Needham & Company LLC from $108.00 to $101.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MMSI provided by MarketBeat